### Tata Elxsi: CMP: 6203: Long Term: Sales 17% | Cy Sales 6.6% |Q3_Fy_25 Result Update | Profit From It
๐Ÿ“ข 5 STEPS TOWARDS WEALTH ๐Ÿš€ The Indian Stock Market Way
๐Ÿ“ข 5 STEPS TOWARDS WEALTH ๐Ÿš€ The Indian Stock Market Way
๐Ÿ“ Delhi | 22nd March 2025 | Saturday / ๐Ÿ•• 5:59 PM - 9:01 PM (Entry from 5:30 PM onwards)
REGISTER NOW
1800 890 4317
profitfromit1@gmail.com

### Tata Elxsi: CMP: 6203: Long Term: Sales 17% | Cy Sales 6.6% |Q3_Fy_25 Result Update

Lesson 46/223 | Study Time: 5 Min

### Tata Elxsi: CMP: 6203: Long Term: Sales 17% | Cy Sales 6.6% |Q3_Fy_25 Result Update


### About the Company

Tata Elxsi is a global leader in design and technology services, catering to various industries, including Transportation, Media, Communications, Healthcare, and Medical Devices. Established in 1989, Tata Elxsi offers integrated services from research and strategy to software development and deployment. The company leverages digital technologies such as IoT, Cloud, Mobility, VR, and AI to help clients innovate and reimagine their products and services.


### Peer Group Comparison

- **Peers**: Infosys, Wipro, Tech Mahindra, HCL Technologies, and Mindtree.

- **Size Comparison**: Tata Elxsi, with a revenue of โ‚น926.5 Cr, is smaller compared to larger peers like Infosys and Wipro but shows significant growth potential in niche markets like SDV, healthcare, and media communications.


### Industry Outlook

- The industry is seeing a shift towards digital transformation, AI, and software-defined solutions. With the increasing demand for SDVs, connected devices, and advanced medical solutions, Tata Elxsi is well-positioned to leverage its expertise in these areas for future growth.


### Historical Performance

- We saw the strong historical performance from this company: 

FY2004: Sales & Profits were 155 Cr & 17 Cr

FY2014: Sales & Profits were 788 Cr & 75 Cr

FY2024: Sales & Profits were 3674 Cr & 792 Cr

This shows the strong growth of 17% CAGR during Last 2 decades, Maintaining the Profit margins of 14% with consistent Profits. Hence the same effect was seen in their Prices: 

FY2004: Prices were 40 Rs & Dividend of 1.5

FY2014: Prices were 273 Rs & Dividend of 6

FY2024: Prices are 7119 Rs & Dividend of 70

This shows the strong growth of 28% CAGR during Last 2 decades along with high and consistent dividends. Today's dividends are almost 50% of Invested value of fy_04. 


### Current Trend Till Last Quarter Q2_fy24

CC Growth, Hence revenue growth was muted along with fall in profits margins made the pressure on Profits. 


### TATAELXSI's Q3 FY25: 


1. Revenue and Profit Growth ๐Ÿ“ˆ

  • Q3 FY25 Sales and Profit Growth vs Last Year: The revenue from operations for Q3 FY25 was โ‚น939.2 Cr, representing a year-on-year increase of 2.7% from โ‚น914.2 Cr in Q3 FY24. During H1_fy25 the growth was 8.7%. Q3 came with weak growth. 

  • Profit Margins: The Profit After Tax (PAT) margin for Q3 FY25 was 20.3%, down from 21.7% in Q3 FY24. Compared to Q2 FY25, the PAT margin also decreased from 22.5% to 20.3%.

2. Segmental and Regional Growth ๐ŸŒ

  • Media & Communications and Healthcare: Both segments reported constant currency (CC) QoQ growth, with Media & Communications growing at 0.4% and Healthcare at 1.1% QoQ.

  • Geographical Performance: Revenue growth from India was notable at 21.9% YoY, while Japan and emerging markets grew significantly by 66.8% YoY.

3. Employee Metrics ๐Ÿ‘ฅ

  • Employee Addition and Attrition Ratio: The headcount at the end of Q3 FY25 was 12,878, while it was 12,793 in Q2 FY25. The attrition rate was stable around 12.4%.

4. Important KPIs in Respect to Industry ๐Ÿ“Š

  • EBITDA Margin: The Operating EBITDA margin for the quarter stood at 26.3%, a slight decrease from the previous quarter's 27.9%.

5. Profitability and Valuation Ratios ๐Ÿ’ธ

  • Valuation at Price of โ‚น5998: Considering the low growth F-EPS for Fy_25 seems to be โ‚น134 for Q3 FY25, the Price-to-Earnings (P/E) ratio at the current price would be approximately 45, suggesting a premium valuation likely due to Low growth.


### Fy_25 Outlook

CC growth is still weak. This year we may see weak Revenue & profit growth of 5%. Valuations are still not cheap despite the share in corrections since last year. All those holding for a long time can add more during this whole corrections near 4812 (SIP could be continued even now)  as valuations could be better while once margins are back with growth of more than 15% we may see the rally back towards the pending targets of 12679 in the next 3 Years. 


### Short Term and Long Term Outlook ๐Ÿ”ฎ

  • Short Term: The company is navigating challenges in the automotive industry, especially in the US and Europe, but has secured significant deals that could stabilize revenue streams in the coming quarters.

  • Long Term: Strategic initiatives like the AVENIR SDV software suite and partnerships for cloud-native and hybrid platforms are likely to bolster Tata Elxsi's position in digital and software domains, supporting long-term growth.


### Future Outlook Long Term

- Tata Elxsi expects continued growth driven by its transportation segment, strategic partnerships, and investment in digital and AI technologies. The company aims to expand its business with key customers and secure new deals in the automotive and telecom sectors. We may see Sales reaching to the benchmark of 15000 Cr till fy_2035 while Profits could be reaching to 3000 Cr. Multiyear rally along with consistent profits can be expected over the long run. 


TATA Sons are the promoter; MF are having around 4% stake while Fii hold around 14% stake. 

Disclosure: Do Not Buy or sell before consulting your advisor as the writer may have the position in the above-given stocks or indices


Piyush Patel

Piyush Patel

Product Designer
4.75
Loyal User
Expert Vendor
Golden Classes
King Seller
Fantastic Support
Loyal Writer
Profile

Class Sessions

1- Let us Understand the classification of Listed Indian industries _2023 2- Bajaj Auto: CMP: 9852: Long Term Gr: 11% Cy Growth: 19% | Q2_FY_25 RESULTS UPDATE 3- Eicher Motors: CMP: 2546: Long Term Gr: 15 C Year: 141 4- WONDERLA: 878 Long Term Gr: 15% | CYear Gr: 13% | Fy_24 Result updated 5- ### Wonderla Q1 FY25 Financial Analysis 6- Wonderla Q2 FY25 Full Analysis 7- Qualified institutions placement of equity share for Wonderla Holidays ???? 8- BEL: CMP: 290: Sales Long term: 11% Q1_FY25: 20% | Q1_FY_25 Result Updated 9- ### Bharat Electronics Limited (BEL) Q1 FY25 Financial Analysis 10- INDUSTRY DASHBOARD 11- Balkrisind: CMP: 2340 LongTerm CAGR: 15% | Cy Gr: (-10%) | Q3_FY_24 RESULT UPDATE 12- Auto Tyres & Rubbers Industry 13- 14- 15- 16- 17- 18- 19- 20- 21- 22- 23- 24- 25- 26- MRF: CMP: 80400: Long term Gr: 10 CY Gr: 70 27- FAIR VALUE OF MRF: 28- Useful Links 29- Q1 FY25 results for Balkrishna Industries Ltd: 30- ### Balkrishna Industries: Consolidated Q2 FY25 & H1 FY25 Financial Analysis 31- AMARA RAJA BATTERIES CMP: 1548 | LONG TERM GR: 15% | Q1_fy25 GR: 17% | Q1_fy25 Result Update 32- ### Amara Raja Batteries: Consolidated Financial Results for Q1 FY25 33- Asset Management Companies: Industry DASHBOARD 34- HDFC AMC: CMP: 4604 Sales Gr: Long term: 11% | H1_FY25: 37% Result Update 35- Airlines Industry 36- InterGlobe Aviation: CMP: 4270: SALES GR LT: 20% | FY24: 25% RESULT UPDATE 37- Agro Chemicals 38- PI Industries Q1 FY25 Key Highlights 39- PI Industry: CMP: 3790 Sales Gr long term: 19% CYear: 18% | fy_24 result update 40- INDUSTRY DATA 41- Breweries & Distilleries: 42- UBL: CMP: 1491 | Long term Gr: 19% | Cyear Gr: 27% | Fy_23 Result update on 23rd June 23 43- Radico: CMP: 454: CY SALES: -13 44- Kajaria Ceramics: CMP: 1319 | Long growth: 17% | C_Year Growth: 5% | 9M_Fy_24 Results Update 45- TCS: 4149: Sales Growth Long Term: 16% | 9M_fy25Sales: 5.2% | 9M_FY25 Result Update 46- ### Tata Elxsi: CMP: 6203: Long Term: Sales 17% | Cy Sales 6.6% |Q3_Fy_25 Result Update 47- INFY:CMP: 1751: Sales Growth: 17 Profits: 21 48- INFY FAIR VALUE 49- LTI: CMP: 3874 : Cy Sales 31 LongTerm Sales: 18 50- LTI FAIRVALUE 51- TRIO OF IT INDUSTRY: DATA STUDY 52- Cement & Cement Products: 53- Ultracemco: CMP: 11105: Long term Sales Gr 13% | H1_fy25: 0% | H1_fy25_Result Update 54- SHREE CEMENTS: CMP: 21163: LONG TERM GR: 15 CY GROWTH: 21 H1_FY23 RESULT UPDATE: 16TH OC 55- Shreecement Intrinsic Value 56- Eagleโ€™s Eye View: Analysis for UltraTech Cement's Q2 FY25: 57- HAVELLS: CMP: 1636 | Long Term: 15% | | Q2_FY25 Sales Gr: 16% | Q2_FY_25 Result Update 58- *Havells India* Limited's Q1 FY25 results: Eagleโ€™s Eye View: 59- Cigarettes, Tobacco Products: 60- FAIR VALUE: ITC 61- Civil construction industry in India: 62- Larsen & Toubro: CMP: 3690: LONG TERM SALES GR: 16 Q1_FY25: 15% | Q1_fy25 Results Update 63- Rites: CMP: 271: Long Term Gr: 8 CYear -25 64- Fairvalue of RITES 65- Q1 FY25 Results Larsen & Toubro (L&T): 66- ### Larsen & Toubro (L&T) Financial & Operational Summary for Q2 FY25 & H1 FY25 67- India Ratings Affirms Larsen & Toubroโ€™s NCDs at โ€˜IND AAAโ€™/Stable 68- Dmart: CMP: 4183: Long Term Sales: 27% H1_FY25_Sales: 16% |H1_Fy_25 RESULT UPDATE 69- Diversified Commercial Services 70- TEAMLEASE: CMP: 2639 Long Term Growth: 19% CYear Growth: 16% | Q1_FY24 Result Update 7th Sept 71- HINDUNILVR: CMP: 2427 | LONG TERM GR: 10% | CYEAR GR: 3% | Q3_FY_24 RESULT UPDATE 72- PATANJALI: CMP: 1703 CYear Gr:-8%, Long Term Gr: 10% | Q1_Fy25 Result Update 73- Eagleโ€™s Eye View: Patanjali Foods Limited for Q1 FY25: 74- Patanjali's Q2 FY25 financials: 75- Ecommerce Listed Space 76- ZOMATO FAIRVALUE 77- Zomato's latest Q1 FY25 Results: 78- POWERDATA FOR POWER EXCHANGE 79- IEX: CMP: 209: Long term Gr: 15 Cy Gr: 19% | Q1_FY25 Result Update 80- PowerGrid: CMP: 194 Long term gr: 18 Cy Year: -4 81- CDSL: CMP: 1536 : LONG TERM GROWTH:25% CY GROWTH: 72% | Q1_fy25 Result update 82- ### Analysis of IEX Q1 FY25 Financial Results 83- Finance Including NBFC: 84- Bajaj Finance: CMP: 6610: LT SALES GR: 25% | Q1_FY25_GR: 29% |Q1_fy_25 Results Update 85- IRFC: CMP: 174 | LONG TERM GR: 15% | CYEAR GR: 12% | FY_24 RESULT UPDATE 86- IREDA: CMP: 147 Long term Gr: 20% | Cyear Gr: 35% 9M_FY_25 Result Update 87- Recltd :CMP: 139: 88- Financial results of Indian Railway Finance Corporation (IRFC) for Q1 FY25: 89- *Indian Railway Finance Corporation Limited (IRFC) for Q2 FY25:* 90- Relaxo Footwear: CMP: 836 9M_fy_24 Result updated 91- ## Relaxo Footwears Limited Q1 FY25 Results Analysis 92- Fertilizer 93- Coromandel: CMP 789: Sales growth long term: 12 Cyear: 11 94- DataStudy of Coromandel 95- ICICI GI: 1904 Long Term Sales Gr: 14% | H1_FY25 GR: 15% Q2_fy25 Result Update 96- ICICI GI: 1904 Long Term Sales Gr: 14% | H1_FY25 GR: 15% Q2_fy25 Result Update 97- Eagle's Eye View on ICICI Lombard's Q1_fy25 and insights: 98- Titan Ind CMP: 3769: Long term Sales: 19% | Q1_fy25: 23% q1_FY25 Latest result Update 99- Pageind: CMP: 40187: long term Sales: 19 CYear:55 H1 result update 12th Nov 100- DashBoard of Titan & Page 101- ### Titan Company Limited Q1 FY25 Financial Analysis 102- PAGE INDUSTRIES: CMP: 38982 | Long term Gr: 21% | C Year: (-3%) | FY24 Result Update 103- ### Page Industries Q1 FY25 Financial Analysis and Insights 104- TTK PRESTIGE: CMP: 698 | LONG TERM GR: 12% | CYEAR:(-5%) | Q3_FY_24 RESULT 105- Voltas: CMP: 1778: Sales Gr Long Term: 12% | Q1_fy25: 47% 106- Housing finance companies: 107- *Bajaj Housing Finance Limited (BHFL)* : CMP: 130 Long Term Gr: 30% | CY Gr: 24% 108- HDFC: CMP: 2342 Cy Sales: -2 LongTerm Sales: 23 9M Result Update on 24th Feb-22 Low Dem 109- FAIRVALUE HDFC 110- Lal PathLabs Ltd: CMP: 2752 | LONG TERM GR: 15% | CY GR: 10% | FY24 RESULT UPDATE 111- Healthcare Facilities: Long Term Sales: 17 CYear: -6 112- Apollo Hospital: 6504: Sales Gr Long term: 17% | CY: 15% Q3_fy24 Result Update 113- ### **Apollo Hospitals Q1 FY25 Financial Analysis** 114- Holding Companies: 115- Bajaj Finserv: cmp: Intrinsic Value 116- Bajaj Finserv: cmp: 5952: 117- Internet & Catalogue Services Industry 118- Naukri: CMP: 6780: Long Term Growth: 17 CYear: 8% | FY_24 Result Update 119- Highlights for Info Edge (India) Limited's FY24 results and Q4 FY24 120- Iron & steel Interim. Products 121- JSW Steel: CMP:901: Long term growth: 15% | Q1_fy25 Growth: 1.7% Result Updated 122- TataSteel: CMP: 1088 Sales Gr: 5 Profit Gr: 6X 123- INDUSTRY DATA 124- LTTS: CMP: 4966: LONG TERM GR: 15% Q2_FY_25: Gr: 8% Result Update 125- Advertising & Media Industry 126- AFFLE: CMP: 1528: Long term gr: 49% | Cy Growth: 28% | Q1_FY_25 Result Updated 127- Eagleโ€™s Eye view: *L&T Technology Services (LTTS)* Q1 FY25 results: 128- ### Affle (India) Limited Q1 FY25 Analysis 129- Affle (India) Limited's Q2 FY25 130- Let us Understand the classification of Listed Indian industries 131- Life Insurance Industry 132- HDFC LIFE: CMP: 752: Premium GROWTH LT: 18% | Q2_FY25: 12% Result Update 133- SBI LIFE: CMP: 1076: 1.3x increase in number of claims reported from FY21 to Q1-FY22. 134- SBILIFE FAIRVALUE 135- Route Mobile: CMP: 1791 LONG TERM GROWTH 37% | fy_24: 13% Result Update 136- ### Eagleโ€™s Eye View: Route Mobile Q1 FY25 Analysis 137- Non Alcoholic Beverages 138- VBL: CMP: 1004 Long Term Gr: 17 CY Growth: 34 139- Data Study 140- HDFCBANK: CMP: 1766 | Sales LONG TERM: 20% | SALES Q2_FY25: 13 % 141- Yes Bank: cmp: 15: Cy Sales: -31 Profit: 129 142- ### Eagleโ€™s Eye view: HDFC Bank Q1 FY25 Results Analysis 143- Paints: 144- Asian paints: CMP: 2946: Long Term Gr: 16% | CYear: (-2%) | Q1_FY_25 Result Update 145- Kajaria Cera: 1174: Long term sales: 12 CYear Sales: 79 Q1 Result Update on 29th July-2 146- FAIRVALUE OF KAJARIA 147- SFL: 3407 Long Term Sales: 17 CYear: 30 Huge Demand But Inflations Hurt Profits 9M Re 148- SFL FairValue 149- SBIN:CMP: 817 Sales Gr: 15% | CYEAR GR: 26% | fy24 Result Update 150- SUPREMEIND: CMP: 4803 LONG TERM GR: 13% Q2_fy25 GR: (-2%) | RESULTS UPDATE 151- SUPREMEIND: CMP: 4803 LONG TERM GR: 13% Q2_fy25 GR: (-2%) | RESULTS UPDATE 152- ### Supreme Industries Q2 FY25 Financial Analysis 153- Pharmaceuticals: 154- Divis Lab: CMP 3796: Sales Long Term: 19% CYear: (-24%) Q1_Fy_24 Result Update 12/09/23 155- Pfizer: CMP: 4538: Long Term Sales Gr: 6 CYear: 4 156- Abbott India: CMP 16015: Long Term Gr: 15 CY Gr: 5 157- Sun Pharma: cmp 526: Sales: -9 Profits: Loss 158- Aplltd: cmp: 984: Sales Growth: 28Profit Growth: 65 159- Ajanta Pharma: cmp: 1461: 160- DataBase Of Pharma World 161- ### Divi's Laboratories Limited: Q1 FY25 Financial Analysis 162- Britannia: CMP: 4913: LONG TERM GR: 12% | CYEAR GR: 3% | Q3_FY_24 RESULT UPDATE 163- NESTLE INDIA 2776 Long Term Gr: 11% | H1_fy25 RESULT: SALES GR: 2% 164- Maruti: CMP: 12389: Sales LongTerm: 14%, Sales Q1_FY25: 10% | Q1FY25 RESULT UDPATE 165- M&M: CMP: 892 : LONG TERM GR: 12 CYEAR GR: 30 H1 RESULT UPDATE: 9TH NOV-21 166- FAIR VALUE M&M 167- Personal Care Dashboard 168- Godrej Cons: CMP: 759: Long Term Sales Gr: 12 CYear: 11 169- Godrej Consumer FAIR VALUE 170- Marico: Cmp: 528 : Sales Gr: Long Term: 9 Cyear: 10 171- COLGATE: Cmp: 1600: Sales Gr: 3 Profits: 18 172- Dabur: CMP: 503: Sales Gr: LongTerm: 7 Cyear: 14 173- Jubilant Foods: CMP: 687 Long term Gr: 14% | Q1_FY_25 Gr: 45% 174- Jubilant FoodWorks Limited Q1 FY25 Financial Performance Overview 175- Reliance Industries: CMP: 2719 LT Sales: 13% | CY: Sales: 6% | H1_FY_25 RESULT UPDATE 176- ### *Eagleโ€™s Eye view Analysis of Reliance Industries' Latest Consolidated Results for Q1 FY25*: 177- Chairman's statement at the 47th Annual General Meeting (AGM) of Reliance Industries Limited: 178- Godrej Properties: CMP: 3299 Long Term Gr: 12% | Cyear gr: 35% fy24 Result Update 179- TEAMLEASE: CMP: 2244 Long Term Gr: 18% | C_Year Gr: 21% Result update: 30th May_23 180- MAPMYINDIA: CMP: 3069 | LONG TERM GR: 25% | Q1_fy25: 14% | Q1_fy25 Result Update 181- INDUSTRY DATA 182- ### MapmyIndia Q1 FY25 Financial Analysis and Insights 183- ???? Q2 FY25 Results Analysis for MapMyIndia 184- ???? New Update for MapmyIndia (C.E. Info Systems Limited): 16% Plus today 185- Specialty Retail: 186- PVR: 1599: Sales growth LT: 28 CY: 702 9M RESULT UPDATE ON 4TH FEB-22 187- PVR: FAIRVALUE 188- Specialty Chem Industry 189- Pidilitind: CMP: 3013: Long Term Gr: 16% | Current Year: 5% | FY_24 Result Update 190- TATA CONSUMER: CMP: 960 | Long term Gr: 12% , H1Fy25 Gr: 15% 191- ### Tata Consumer Products Limited Q2FY25 Financial Analysis 192- AU Small Finance Bank: CMP: 599: Long term Gr: 34% Cy Gr: 34% | Q3_FY24 Result Update 193- ### AU Small Finance Bank Q1 FY25 Financial Analysis 194- IRCTC: CMP: 918 LONG TERM GR: 18% | Q1_fy25 GR: 12% | RESULTS UDPATE 195- Telecom Services: LT Growth :14 CAGR Cy Year Growth: 21 196- Bharti Airtel: CMP 697: Long Term Sales: 12 CYear: 12 H1 RESULT UPDATED 3RD NOV-21 197- Bharti Airtel: Intrinsic Value 198- Textiles Industry 199- Textiles Industry DataStudy 200- KPR Mill: CMP: 464: Sales Growth: 43 H1 201- VTL: CMP: 830: Sales Growth -21 202- Garware Technical Fibres Ltd: CMP: 2158: CY Sales: -9 203- ### EMS Ltd Q1 FY25 Results Analysis 204- $50 million loan agreement between the Government of India and the Asian Development Bank (ADB) 205- Indias Largest Companeis in 2030: SUPER-21 206- Utilities Non_electric: longterm Gr: 17 CYear -19 Covid Affected Industry 207- Gail: CMP: 143 : long term Gr: 11 CYear: 44 208- IGL: cmp: 537: Long Term: 21 CYear: -32 209- MGL: cmp: 1107: Long Term Gr: 12 CYear: -28 210- FairValue of MGL 211- Indias TOP 3 Companies would be Crossing 1 Lakh Cr Profits during 2025-30. 212- Reliance Ind: Long Term Gr: 15 CAGR 213- TCS: Long Term Gr: 20 CAGR 214- HDFCBank: LongTerh Gr 22 CAGR 215- Nifty-6 Document 216- Nifty-6 DashBoard 217- Biotechnology 218- Biocon: CMP: 360: Long Term Growth of 15 CY Growth 10 9M Result Updated on 27th Jan-22 219- FAIRVALUE of BIOCON 220- Tata Consultancy Services (TCS), detailing their new partnership with Landis+Gyr 221- ZOMATO: CMP: 274 Long Term Growth: 56% Q1_fy25 Growth: 75% Q1_fy25 Result Update 222- ### Divi's Laboratories Limited: Q1 FY25 Financial Analysis 223- Tata Elxsi Technical Chart